Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Head and Neck (SCCHN)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03726775
What this trial is testing

Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN

Who this might be right for
HNSCC
Groupe Oncologie Radiotherapie Tete et Cou 61
Testing effectiveness (Phase 2)Ended earlyNCT01305772
What this trial is testing

Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Neal Ready 6
Testing effectiveness (Phase 2)Study completedNCT05077709
What this trial is testing

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

Who this might be right for
Lung Cancer Non Small CellHead and Neck Squamous Cell CarcinomaUrothelial Carcinoma Bladder
IO Biotech 63
Early research (Phase 1)Looking for participantsNCT07460765
What this trial is testing

Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
HnsccHead and NeckSquamous Cell Cancer+8 more
Vanderbilt-Ingram Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00995293
What this trial is testing

Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial

Who this might be right for
Head and Neck Neoplasms
Sanofi 240
Testing effectiveness (Phase 2)WithdrawnNCT00084435
What this trial is testing

S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Active Not RecruitingNCT03341936
What this trial is testing

Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Dana-Farber Cancer Institute 29
Large-scale testing (Phase 3)Study completedNCT00101582
What this trial is testing

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
MucositisSolid TumorsStomatitis+2 more
Swedish Orphan Biovitrum 188
Not applicableStudy completedNCT01080066
What this trial is testing

A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Merck KGaA, Darmstadt, Germany 215
Testing effectiveness (Phase 2)UnknownNCT03771820
What this trial is testing

Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen

Who this might be right for
SCCHN
NanoCarrier Co., Ltd. 136
Testing effectiveness (Phase 2)Ended earlyNCT03440437
What this trial is testing

FS118 in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMetastatic CancerSquamous Cell Carcinoma of Head and Neck
invoX Pharma Limited 80
Testing effectiveness (Phase 2)WithdrawnNCT03325465
What this trial is testing

Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Chicago
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT03529422
What this trial is testing

Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN

Who this might be right for
LarynxLipOral Cancer+1 more
UNC Lineberger Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00371566
What this trial is testing

Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
GlaxoSmithKline 107
Testing effectiveness (Phase 2)Study completedNCT03878979
What this trial is testing

Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck CancerHead and Neck Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Testing effectiveness (Phase 2)Study completedNCT02499120
What this trial is testing

Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Pfizer 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT05977907
What this trial is testing

Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Not applicableEnded earlyNCT01142869
What this trial is testing

An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Carcinoma, Squamous Cell
Merck KGaA, Darmstadt, Germany 133
Testing effectiveness (Phase 2)Study completedNCT03723967
What this trial is testing

FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Centre Leon Berard 104
Next Page